推进抗菌光动力疗法以预防骨整合假体患者的感染
This will be a prospective observational trial enrolling 20 patients with osseointegrated prostheses. Participants will be recruited from the orthopaedic outpatient clinic at Walter Reed National Military Medical Center in Bethesda, MD.
All eligible consenting patients will undergo daily stoma management per standard of care.
Patients will integrate antimicrobial photodynamic therapy into their stoma management program. The first treatment will take place in the orthopaedic clinic. All others will take place at home. Topical 5-ALA will be applied to the metal at the penetration site. After 2 hours, the light delivery device will be utilized and light will be administered for 15 minutes.
Data collection: After obtaining informed consent, study personnel will record injury-specific variables, surgery-specific variables, other variables related to their hospital course, demographic variables as well as comorbidities on the study case report forms (CRFs). They will obtain this information directly from the participant, from the participant's medical record, and the participant's treating orthopaedic surgeon or other health care providers. Baseline data collection points include participant characteristics and amputation details such as age, sex, comorbidities, highest education level achieved, social support, initial reason for amputation, type of amputation and all surgical dates. Study participants will be followed at 1 and 2 weeks after initiation of PDT treatment. To ensure research participant safety, serious adverse events (SAEs) will be documented and promptly submitted to the local IRB as per the required reporting processes.
Follow-up: Study participants will be followed at 1 week and 2 weeks.
研究概览
地位
地位
干预/治疗
干预/治疗
研究类型
研究类型
注册 (估计的)
注册
联系人和位置
学习联系方式
学习联系方式
- 姓名:Devin Mullin
- 电话号码:603-650-6032
- 邮箱:Devin.S.Mullin@hitchcock.org
研究联系人备份
- 姓名:Ida Gitajn
- 电话号码:603-650-6032
- 邮箱:Ida.Leah.Gitajn@hitchcock.org
学习地点
-
-
Maryland
-
Bethesda、Maryland、美国、20889
- Walter Reed National Military Medical Center
-
接触:
- Christopher H Renninger, MD
- 电话号码:(202)-929-0618
- 邮箱:christopher.h.renninger.mil@health.mil
-
接触:
- Qingfeng Liu
- 电话号码:(240) 645-3068
- 邮箱:Qingfeng.liu.ctr@usuhs.edu
-
-
参与标准
资格标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
取样方法
研究人群
All patients >18 years with osseointegrated prostheses are eligible. Patients will be excluded if they have an ongoing infection, are pregnant or if it is anticipate that they will have issues with compliance or follow-up.
描述
Inclusion Criteria:
- All patients with osseointegrated prostheses 18 years of age or older
Exclusion Criteria:
- Ongoing infection
- Pregnant
- Anticipated issues with compliance or follow-up
学习计划
研究是如何设计的?
设计细节
- 观测模型:COHORT
- 时间观点:PROSPECTIVE
团体/队列数
队列和干预
团体/队列团体/队列 |
干预/治疗干预/治疗 |
|---|---|
|
Osseointegration patients
All patients >18 years with osseointegrated prostheses. |
All patients who are recruited and enrolled into this study use topical 5- ALA, in combination with the light delivery device as part of their standard stoma management. All patients who are recruited and enrolled into this study use topical 5- ALA, in combination with the light delivery device photodynamic therapy device as part of their standard stoma management. |
研究衡量的是什么?
主要结果指标
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Feasibility
大体时间:2 weeks
|
Feasibility will be defined as 80% of patients successfully completing the administration protocol as well as 1 week/2-week follow-up. |
2 weeks
|
次要结果测量
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Treatment Evaluation Inventory-Short Form (TEI-SF)
大体时间:2 weeks
|
The TEI-sf is a 9-item questionnaire used to measure intervention acceptability from the participants point of view. Scores range from 9 to 45, and scores above 27 are considered acceptable. |
2 weeks
|
|
System Usability Scale (SUS)
大体时间:2 weeks
|
The SUS is a reliable 10-item usability measure with scores that range from 0 to 100 (an above average score is 68 or higher. |
2 weeks
|
|
Bioburden quantification (16S rRNA sequencing)
大体时间:2 weeks
|
Bioburden will be quantified using quantitative PCR-based assays as well as addition of a "spikein" of a defined quantity of bacterial cells derived from halophilic organism Salnibacter ruber. |
2 weeks
|
|
Bioburden quantification (Optical Coherence Tomography (OCT)
大体时间:2 weeks
|
Biofilm will be imaged and quantified on the metal abutment |
2 weeks
|
|
OCT "virtual biopsy"
大体时间:2 weeks
|
Presence of inflammation, hypergranulation, and any resulting changes (e.g., the degree of epidermal regression, dermal attachment to the implant, and epithelial layer thickness) can be quantified through morphologic analysis of the OCT B-scans. Scars are characterized by excessive collagen deposition, increased blood vessel density, and parallel blood vessel organization compared with normal skin. |
2 weeks
|
|
Scar thickness
大体时间:2 weeks
|
Scar thickness measured using OCT |
2 weeks
|
|
Blood vessel density
大体时间:2 weeks
|
Blood vessel density measuring using OCT |
2 weeks
|
|
Presence of hypergranulation
大体时间:2 weeks
|
Hypergranulation measured using OCT |
2 weeks
|
|
Pain during light exposure
大体时间:2 weeks
|
Patient reported pain during light exposure |
2 weeks
|
|
Discomfort, burning, itchiness, or redness
大体时间:2 weeks
|
Patient reported discomfort, burning, itchiness or redness |
2 weeks
|
合作者和调查者
研究记录日期
研究主要日期
学习开始 (估计的)
学习开始
初级完成 (估计的)
初级完成
研究完成 (估计的)
研究完成
研究注册日期
首次提交
首次提交
首先提交符合 QC 标准的
首先提交符合 QC 标准的
首次发布 (实际的)
首次发布
研究记录更新
最后更新发布 (实际的)
最后更新发布
上次提交的符合 QC 标准的更新
上次提交的符合 QC 标准的更新
最后验证
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.